期刊文献+

基于文献研究视角的基本药物可及性问题研究 被引量:8

The research of problems existing in the accessibility of essential drugs based on the literatures research
下载PDF
导出
摘要 本文通过文献分析的方法对基本药物可及性中存在的问题进行论证,并运用统计学方法找出这些问题中需要优先解决的问题。结果显示基本药物可及性存在的诸多问题,覆盖了从基本药物的遴选到使用的整个过程。在这些问题中,最需要优先解决的是企业不生产或少生产基本药物的问题,其次是医师不优先使用基本药物的问题,然后是基本药物配送环节的不合理加价问题。 Demonstrate the problems existing in the accessibility of essential drugs by researching the literatures. Then use the statistical methods to find the problems that should be given priority to solve. There are numerous problems in the accessibility of essential drugs. But not all the problems are the same important. And the problem that most should be given priority to solve is that pharmaceutical companies do not want to produce essential drugs. The second is that essential drugs are not priority to doctors. The third problem which most should be given priority to solve is the unreasonable price increase in the distribution of essential drugs.
出处 《药品评价》 CAS 2012年第8期6-12,共7页 Drug Evaluation
关键词 基本药物可及性 文献研究 优先解决 accessibility of essential drugs literature research priority to solve
  • 相关文献

参考文献5

  • 1席晓宇,符一男,褚淑贞.健康公平性视角下的中国药品可及性探讨[J].药品评价,2010,7(18):20-22. 被引量:12
  • 2胡永宏,贺思辉.《综合评价方法》[M].科学出版社,2000第一版.
  • 3贾生华,陈宏辉.利益相关者的界定方法述评[J].外国经济与管理,2002,24(5):13-18. 被引量:517
  • 4中华人民共和国卫生部,处方管理办法(53号令)[EB/OL].http:/www.gov.cn/ziliao/flfg/2007-03/13/content_549406.htm,2007,03.
  • 5卫生部,国家计委.关于印发医疗机构药品集中招标采购试点工作若干规定的通知(卫规财发(2000)232号)http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohghcws/pzbcg/200804/29770.htm,2007,7.

二级参考文献11

  • 1A. Farina and A. ProtopapaRadar Dpt Selenia S. p. A., Via Tiburtina,Km. 12,400-00131 Rome, Italy.Channel Mismatching in Sidelobe Canceler: Limitations and Remedies[J].Journal of Systems Engineering and Electronics,1992,3(3):23-43. 被引量:2
  • 2杨军.TRIPS协议修改对中国艾滋病药品可及性的影响及应对策略[J].新疆社会科学,2006(2):77-80. 被引量:7
  • 3Blair M.M.and Stout L.A.,Response to Peter C Kostant's Exit,Voice and Loyalty in the Course of Corporate Governance and Counsel's Changing role[J].Journal of Socio-Economics,1999,28(3):251-253.
  • 4Knut H.M.and Svein J.,From User-groups to Stakeholders?The Public Interest in Fisheries Management[J].Marine Policy,2001,25(4):281-292.
  • 5Michael J.P.and Jacquelyn A.O.,Exploratory Examination of Whether Marketers Includs Stakeholders in the Green New Product Development Process[J].Journal of Cleamer Production,1998,6(3-4):269-275.
  • 6Mitchell A.and Wood.Toward a Theory of Stakebolder Identification and Salienca:Defining the Principle of Who and What Really Counts[J].The Academy of Management Review,1997,22(4):853-886.
  • 7Thayer C.E.and Fine A.H.,Evaluation and Outcome Messurement in the Non-Profit Sector:Stakebolder Participation[J].Evaluation and Program Planning,2001,24(1):103-108.
  • 8Wheeler D.and Maria S.,Including the Stakeholders:The Business Cade[J].Long Range Planning,1998,31(2):201-210.
  • 9龚时薇,詹学锋.国家药物政策体系与类型分析[J].中国药事,2009,23(1):37-42. 被引量:8
  • 10饶克勤,姚岚,秦立轩.健康公平的测量方法[J].中国卫生经济,1998,17(12):30-32. 被引量:55

共引文献526

同被引文献80

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部